Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
Top Cited Papers
Open Access
- 30 September 2020
- journal article
- research article
- Published by European Respiratory Society (ERS) in ERJ Open Research
Abstract
Background: Many patients with COVID-19 did not require hospitalisation, nor underwent COVID-19 testing. There is anecdotal evidence that patients with "mild" COVID-19 may complain about persistent symptoms, even weeks after the infection. This suggests that symptoms during the infection may not resolve spontaneously. The objective of this study was to assess whether multiple relevant symptoms recover following the onset of symptoms in hospitalised and nonhospitalised patients with COVID-19. Methods: A total of 2113 members of two Facebook groups for coronavirus patients with persistent complaints in the Netherlands and Belgium, and from a panel of people who registered on a website of the Lung Foundation Netherlands, were assessed for demographics, pre-existing comorbidities, health status, date of symptoms onset, COVID-19 diagnosis, healthcare utilisation, and the presence of 29 symptoms at the time of the onset of symptoms (retrospectively) and at follow-up (mean +/- SD 79 +/- 17 days after symptoms onset). Results: Overall, 112 hospitalised patients and 2001 nonhospitalised patients (confirmed COVID-19, n=345; symptom-based COVID-19, n=882; and suspected COVID-19, n=774) were analysed. The median number of symptoms during the infection reduced significantly over time (median (interquartile range) 14 (11-17) versus 6 (4-9); p<0.001). Fatigue and dyspnoea were the most prevalent symptoms during the infection and at follow-up (fatigue: 95% versus 87%; dyspnoea: 90% versus 71%). Conclusion: In previously hospitalised and nonhospitalised patients with confirmed or suspected COVID-19, multiple symptoms are present about 3 months after symptoms onset. This suggests the presence of a "post-COVID-19 syndrome" and highlights the unmet healthcare needs in a subgroup of patients with "mild" or "severe" COVID-19.Funding Information
- Lung Foundation Netherlands (4.1.16.085, 5.1.18.232)
- ZonMw (ERACoSysMed 90030355)
This publication has 20 references indexed in Scilit:
- Mild or Moderate Covid-19The New England Journal of Medicine, 2020
- Persistent Symptoms in Patients After Acute COVID-19Jama-Journal Of The American Medical Association, 2020
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studyLancet, 2020
- Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019Journal of Internal Medicine, 2020
- COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysisJournal of Medical Virology, 2020
- Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort studyBMJ, 2020
- Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)Science, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled studyBMC Neurology, 2011
- Mental Morbidities and Chronic Fatigue in Severe Acute Respiratory Syndrome SurvivorsArchives of Internal Medicine, 2009